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ABSTRACT
DNA assembly allows individual DNA constructs or
libraries to be assembled quickly and reliably. Most
methods are either: (i) Modular, easily scalable and
suitable for combinatorial assembly, but leave un-
desirable ‘scar’ sequences; or (ii) bespoke (non-
modular), scarless but less suitable for construc-
tion of combinatorial libraries. Both have limitations
for metabolic engineering. To overcome this trade-
off we devised Start-Stop Assembly, a multi-part,
modular DNA assembly method which is both func-
tionally scarless and suitable for combinatorial as-
sembly. Crucially, 3 bp overhangs corresponding to
start and stop codons are used to assemble coding
sequences into expression units, avoiding scars at
sensitive coding sequence boundaries. Building on
this concept, a complete DNA assembly framework
was designed and implemented, allowing assembly
of up to 15 genes from up to 60 parts (or mixtures);
monocistronic, operon-based or hybrid configura-
tions; and a new streamlined assembly hierarchy
minimizing the number of vectors. Only one destina-
tion vector is required per organism, reflecting our
optimization of the system for metabolic engineer-
ing in diverse organisms. Metabolic engineering us-
ing Start-Stop Assembly was demonstrated by com-
binatorial assembly of carotenoid pathways in Es-
cherichia coli resulting in a wide range of carotenoid
production and colony size phenotypes indicating
the intended exploration of design space.
INTRODUCTION
In recent years, new types of DNA cloning methods of-
ten referred to as DNA assembly have been reported which
are much more suitable for combining multiple DNA se-
quence elements or ‘parts’ in a single step than conventional
restriction-ligation cloning (1). These multi-part DNA as-
sembly methods can mostly be categorized into one of two
types: (i) Modular approaches, in which a framework of
specified steps, rules and design constraints including pre-
defined module formats allows highly efficient multi-part
assembly of individual constructs or designed combinato-
rial mixtures of constructs. However, these benefits come
at the cost of fixed ‘scar’ sequences at junctions between
parts in the assembled construct and a substantial upfront
investment of effort and resources to obtain a required set
of suitable assembly vectors, and to prepare sequences of
interest in the appropriate format. (ii) Bespoke approaches,
which are flexible, require little upfront effort to establish or
planning of future steps, and typically involve an ad hoc ap-
proach to the design of cloning strategies which is intuitively
more similar to conventional cloning approaches. However,
these non-modular approaches depend on sequence over-
laps to direct assembly, so they have a greater need for cus-
tom oligonucleotide primers (typically one pair per junc-
tion between parts) and sequence verification (due to PCR
steps) and are less suitable for combinatorial assembly due
to lower efficiency (meaning fewer clones are obtained fol-
lowing transformation so smaller libraries are generated)
and greater potential for bias particularly due to repetitive
sequences. Modular multi-part DNA assembly methods in-
clude Golden Gate assembly (2–4) (and variants (4–14)),
BASIC (15), BioBrick assembly (16) (and variants such as
BglBrick (17,18)) and Gateway cloning (19–21). Bespoke
multi-part DNA assembly methods include Gibson Assem-
bly (22), AQUA cloning (23), Twin Primer Assembly (24),
ligase cycling reaction (25), SLIC (26), SLiCE (27), overlap
extension PCR (28) and CPEC (29). Multi-part DNA as-
sembly has quickly become important in synthetic biology,
enabling an increase in the scale, scope and speed of studies
(1).
The development of effective metabolic pathway-
encoding constructs is a key application for multi-part
DNA assembly. The amount of a protein produced by an
expression construct depends on the expression control
parts used (particularly promoters, ribosome-binding
sites (RBSs) and transcriptional terminators) as well as
the coding sequences (CDSs), which affect expression
through mRNA structure and codon usage. The design
of a multi-protein expression construct, such as those en-
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coding metabolic pathways, involves a multi-dimensional
‘design space’, in which the concentration of each protein
represents a dimension (30–34). Within any such design
space there will be regions of functional pathway-encoding
designs, including local optima, but also regions of poorly-
functional or non-functional pathway-encoding designs.
Natural metabolic pathways, and the sequences encoding
them, are optimized by natural selection for efficient
formation of the intended product, and to avoid delete-
rious effects on the cell (35). In contrast, heterologous
or synthetic metabolic pathways can be non-optimal in
various ways including poor flux through the pathway
to the intended product, the formation of by-products,
the accumulation of intermediates (which may be toxic),
excessive enzyme overexpression (36,37) and deleterious
effects on the cell caused by one or more of these issues
(32,34,36,38,39). These issues depend largely on the profile
of absolute and relative concentrations of the enzymes in a
pathway. In principle, metabolic modelling methods allow
prediction of suitable enzyme concentration profiles for a
particular pathway in a given host organism. In practice,
predictive modelling approaches are generally demand-
ing, requiring suitable metabolic models and parameter
values which may not be available. Furthermore, even
if an optimal enzyme concentration profile is known, at
present it is difficult or impossible to rationally design an
individual DNA sequence to express a protein of interest
to a specific target concentration (30), a problem which
increases in difficulty with increasing numbers of proteins
in a multi-protein expression construct (30,31).
Modular multi-part DNA assembly facilitates generally-
applicable strategies to identify and optimize metabolic
pathway-encoding constructs from among the many pos-
sible designs for any given pathway. Firstly, efficient as-
sembly is not limited to construction of individual expres-
sion constructs, but can be used to generate combinatorial
libraries of multi-protein expression constructs, in which
the expression of each protein is varied independently, or
partially-independently, by using mixtures of expression
control parts instead of individual expression control parts
(31,32,40–42). The design of such mixtures (in terms of the
number of parts and the distribution of their expression lev-
els) will determine the distribution and granularity of sam-
pling of design space with respect to the relevant protein,
allowing for tunable search strategies effective for large de-
sign spaces, limited primarily by the throughput of screen-
ing once host cells are transformed with the library. Sec-
ondly, once functional metabolic pathway-encoding con-
struct designs are identified, modular DNA assembly facil-
itates rational optimization of these through further, more
fine-grained rounds of combinatorial searches, and/or by
manually-designed substitutions of specific expression con-
trol parts (31,40,41). Compared to predictive modelling,
these approaches are pragmatic and empirical, requiring lit-
tle a priori knowledge of suitable enzyme concentrations,
nor of the protein concentrations that will result from par-
ticular combinations of expression control parts and CDSs.
Themain requirements for these approaches are suitable ex-
pression control parts which span an appropriate range of
strengths, and a suitable modular multi-part DNA assem-
bly method.
Of the modular DNA assembly methods, Golden Gate
assembly (2,3) and variants (4–14) are particularly widely
used, including for construction of metabolic pathway-
encoding constructs (10,14,43–45). Golden Gate uses type
IIS restriction endonucleases, which are similar to classical
type II restriction endonucleases, except their restriction site
is offset from their recognition site, rather than within it.
IIS restriction endonuclease sites are asymmetrical, which
confers directionality. Type IIS restriction endonucleases, in
combination with appropriately-designed DNA sequences,
can be used to generate DNA fragments with any desired
cohesive end sequences independently of the sequence of
the recognition site. The cohesive end sequences can be non-
palindromic, avoiding the self-ligation of palindromic cohe-
sive ends like those generated by classical type II endonu-
cleases. Golden Gate assembly uses a series of DNA frag-
ments generated in this way by a single type IIS endonu-
clease (in each assembly step), such that each fragment has
unique non-palindromic cohesive ends designed to anneal
only to the correct end of the next DNA fragment in the se-
ries. Such a series of DNA fragments can be efficiently and
directionally assembled, in the intended order, by ligation.
Furthermore, an efficient ‘one-pot’ assembly reaction con-
taining both ligase and the appropriate type IIS endonucle-
ase can be used (2,3), because unique non-palindromic co-
hesive ends can only either (i) ligate to the intended cognate
cohesive DNA end, in which case the restriction site is not
regenerated, so the ligation product is not subsequently re-
stricted; or (ii) re-ligate to the donor plasmid fragment from
which they were originally excised, in which case the site is
regenerated and can be subsequently restricted again. The
overall effect is that the concentration of the intended as-
sembly product in the one-pot reaction increases over time,
whereas the concentration of original or re-ligated donor
plasmids decreases over time, resulting in very efficient as-
sembly (2,3). One-pot assembly reactions can be performed
under isothermal conditions, but are more efficient if the
reaction temperature is cycled between the different opti-
mal temperatures of the ligase and endonuclease (3). The
GoldenGate approach as originally described (2) effectively
defines a broad strategy, rather than specific details of how
it might generally be applied. Subsequent publications from
various groups have described particular implementations
of Golden Gate, crucially including frameworks for hierar-
chical assembly of numerous parts, and collections of vec-
tors and parts in the relevant formats for these (4,5). These
implementations are mostly focused on specific organisms,
such as plants (4–7), yeast (8–12) orEscherichia coli (13,14).
There is a lack of modular, multi-part assembly systems
which are widely-applicable to many organisms with a min-
imum of cloning effort, which would be very useful.
All the above Golden Gate approaches require specific
‘fusion site’ sequences to be defined for the unique cohe-
sive ends, which are incorporated into the assembled con-
struct as unavoidable scar sequences at the junctions be-
tween parts. Scars therefore impose design constraints on
constructs assembled by Golden Gate and other modular
multi-part DNA assembly methods. At the junction be-
tween some types of parts, scars can have a substantial im-
pact on functional properties. A key example is the junction
between a CDS and the upstream sequence. Scars at this
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junction are transcribed to mRNA, potentially affecting
mRNA structure (which in turn affects functional proper-
ties (46)), RBS accessibility, ribosome binding, and may be
an issue for regulatory approaches achieved using designed
RNA elements, such as riboswitches (47), riboregulators
(48) and small transcription activatingRNAs (STARs) (49).
To illustrate this, we performed a direct comparison of the
impacts of several assembly scars at a junction between a
CDS and the upstream sequence (Supplementary Figure
S1).
It is preferable to minimize constraints on the design of
DNA constructs generally, but particularly in cases where
the desired functional properties of the construct are likely
to be sensitive to the presence of scars. An important exam-
ple is the assembly of individual or combinatorial mixtures
of metabolic pathway-encoding constructs. A DNA assem-
bly system providing efficient modular multi-part assembly,
yet without leading to scars at sensitive positions, would be
widely useful. Here, we develop such a DNA assembly sys-
tem, called Start-Stop Assembly, and demonstrate its utility
for combinatorial assembly of metabolic pathway-encoding
constructs.
MATERIALS AND METHODS
Additional materials and methods are available in the Sup-
plementary Materials.
Bacterial strains and growth conditions
Escherichia coli strain DH10Bwas used for all DNA assem-
bly, all other cloning, and all other experiments described
in this study. Escherichia coli DH10B cells were routinely
grown in LBmedium (tryptone 10 g l−1, yeast extract 5 g l−1
and NaCl 5 g l−1) at 37◦C, with shaking at 225 rpm, or on
LB agar plates (containing 15 g l−1 bacteriological agar) at
37◦C. LB was supplemented with ampicillin (100 g ml−1),
tetracycline (10 g ml−1), kanamycin (50 g ml−1) or chlo-
ramphenicol (25 g ml−1) as appropriate. Escherichia coli
cells were routinely transformed by electroporation (50).
Plasmid construction
Except where stated otherwise, plasmid construction was
carried out using standard molecular cloning methods.
Details are provided in the Supplementary Materials, ta-
bles of plasmids (Table 1 and Supplementary Table S3),
oligonucleotides (Supplementary Table S4) and synthetic
DNA (Supplementary Table S6). This includes a suggested
method to construct alternative Level 2 destination vectors
(Supplementary Figure S6).
Storing genetic parts
Genetic parts were cloned in Level 0 vector pStA0 us-
ing one-pot restriction-ligation assembly reactions (as de-
scribed below) of inserts obtained by PCR amplification or
DNA synthesis, or by inverse PCR using pStA0 as template
and primers incorporating the part sequence. Spacer parts
were generated as double-stranded oligonucleotide linkers
by oligo annealing, and were not cloned for storage. See
Supplementary Materials for details.
Start-Stop Assembly reactions
Start-Stop Assembly reactions contained 20 fmol of desti-
nation vector plasmid DNA, 40 fmol of each insert (plas-
mid DNA or annealed oligonucleotides), T4 DNA Ligase
buffer, 400 units of T4 DNA Ligase and 10 units of the ap-
propriate restriction endonuclease (SapI, BsaI or BbsI) in a
total reaction volume of 20 l. All enzymes and T4 DNA
Ligase buffer were supplied byNew England Biolabs. Reac-
tions were incubated using a thermocycler for 30 two-step
cycles of 37◦C for 5 min then 16◦C for 5 min, before a single
final denaturation step at 65◦C for 20 min. See Note S3 Lab
Protocol.
Analysis of Level 1 assembly fidelity and bias by flow cytom-
etry
Escherichia coli DH10B cells were transformed with Start-
Stop Assembly reactions. Isolated transformant clones or
pools of transformant clones were used to inoculate 5ml LB
broth supplemented with the appropriate antibiotic, which
was cultured overnight (16 h) at 37◦C with shaking at 225
rpm. For flow cytometry analysis, overnight cultures were
subcultured by 1:1000 dilution into 5 ml fresh LB medium
with the appropriate antibiotic and grown for 6 h at 37
◦C with shaking at 225 rpm. Cultures were diluted 1:50 in
filtered PBS and immediately subjected to flow cytometer
analysis.
Fluorescence was measured using an Attune NxT flow
cytometer (Invitrogen). The voltage gains for each detec-
tor were set to ensure all constructs fell within the dy-
namic range: FSC, 440 V; SSC, 440 V; BL1, 500 V. 10 000
events gated by forward scatter height (FSC-H) and side
scatter height (SSC-H) that represent the E. coli cell pop-
ulation were collected at 100 l min−1 sample flow rate.
Flow cytometry data were analysed using FlowJo (http:
//flowjo.com). Cells were gated by FSC-H and SSC-H and
the geometric mean from the BL1 detector was exported as
the fluorescence value.
Coding sequences for carotenoid metabolic pathway libraries
The eight CDSs used in the assembly of carotenoid
metabolic pathway libraries were dxs (encoding 1-
deoxyxylulose-5-phosphate synthase; WP 074468184)
from E. coli MG1655, crtE (encoding geranylgeranyl
pyrophosphate synthase; WP 010888034) from Deinococ-
cus radiodurans R1, crtB (encoding phytoene synthase;
WP 010887508) from D. radiodurans R1, crtI (encoding
phytoene desaturase; WP 010887507) from D. radiodurans
R1, idi (encoding isopentenyl pyrophosphate isomerase;
AAC32208) from Haematococcus pluvialis, lcyB (encod-
ing beta-lycopene cyclase; ABR57232) from Solanum
lycopersicum, crtZ (encoding -carotene hydroxylase;
WP 072137426) from Pantoea ananatis and crtW (en-
coding -carotene ketolase; BAB74888) from Nostoc
sphaeroides PCC 7120. Each CDS was codon-optimized
for expression inE. coli using the OPTIMIZER guided ran-
dom methodology (51). Iterations of the optimization were
repeated until each CDS had a codon adaptation index
(CAI) score >0.65. Each CDS was synthesized as a linear
gBlock DNA fragment (Integrated DNA Technologies).
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Table 1. List of core Start-Stop Assembly vectors. The 15 vector names reflect their level in the hierarchy (number in blue) and their donor fusion sites
(letters or numbers in red) or in the case of Level 3 vectors their acceptor fusion sites (numbers in green). Each vector contains an assembly cassette
(including a lacZα gene for blue/white screening), a resistance marker (AmpR, TetR, KanR or CamR) and a replicon (high-copy pMB1 or low-copy
p15A). Each also has a unique ID number (pGT. . . ). Genbank accession numbers are shown
Plasmid 
Name
Accession 
Number
Level Acceptor 
fusion sites
Donor 
fusion sites
Comments
pStA0 MG649420 0 F-R (BsaI) α-ε (SapI) AmpR, pMB1, lacZα, ID = pGT400
pStA1AZ MG649422 1 α-ε (SapI) A-Z (BsaI) TetR, p15A, lacZα, ID = pGT401
pStA1AB MG649421 1 α-ε (SapI) A-B (BsaI) TetR, p15A, lacZα, ID = pGT402
pStA1BZ MG649424 1 α-ε (SapI) B-Z (BsaI) TetR, p15A, lacZα, ID = pGT403
pStA1BC MG649423 1 α-ε (SapI) B-C (BsaI) TetR, p15A, lacZα, ID = pGT404
pStA1CZ MG649426 1 α-ε (SapI) C-Z (BsaI) TetR, p15A, lacZα, ID = pGT405
pStA1CD MG649425 1 α-ε (SapI) C-D (BsaI) TetR, p15A, lacZα, ID = pGT406
pStA1DZ MG649428 1 α-ε (SapI) D-Z (BsaI) TetR, p15A, lacZα, ID = pGT407
pStA1DE MG649427 1 α-ε (SapI) D-E (BsaI) TetR, p15A, lacZα, ID = pGT408
pStA1EZ MG649429 1 α-ε (SapI) E-Z (BsaI) TetR, p15A, lacZα, ID = pGT409
pStA212 MG649430 2 A-Z (BsaI) 1-2 (BbsI) KanR, p15A, lacZα, ID = pGT417
pStA223 MG649431 2 A-Z (BsaI) 2-3 (BbsI) KanR, p15A, lacZα, ID = pGT418
pStA234 MG649432 2 A-Z (BsaI) 3-4 (BbsI) KanR, p15A, lacZα, ID = pGT419
pStA313 MG649433 3 1-3 (BbsI) N/A CamR, p15A, lacZα, ID = pGT415
pStA314 MG649434 3 1-4 (BbsI) N/A CamR, p15A, lacZα, ID = pGT416
Analysis of phenotypic diversity of carotenoid pathway li-
brary clones by image analysis
Escherichia coliDH10B cells were transformed with 5 l of
Start-Stop Assembly reaction product, allowed to recover
for one hour, plated and grown at 30◦C for 48 h. Transfor-
mation plates were photographed under consistent condi-
tions using a Canon 60D camera. The images were analysed
using OpenCFU v.3.8 beta (52), and colonies were detected
using an inverted threshold of 3 and a minimum radius of
10 pixels and a maximum radius of 500 pixels. The area and
red, green, blue colours of each colony were determined.
Quantification of lycopene content of cells
Escherichia coli was cultured in tubes containing 5 ml LB
supplemented with the appropriate antibiotics and grown
at 37◦C at 225 rpm for 24 h. To obtain the cry cell weight
(DCW), after 24 h cultivation 2ml of liquid culture was cen-
trifuged at 14 000 rpm for 5 min to remove supernatant,
the bacterial cell pellet was washed in ddH2O and then cen-
trifuged again, and dried at 70◦C until a constant weight
was obtained. To obtain lycopene concentrations, follow-
ing 24 h incubation 2 ml of liquid culture was centrifuged
at 14 000 rpm for 5 min to remove supernatant, the bacte-
rial cell pellet was washed in ddH2O and then centrifuged as
before. The bacterial cell pellet was resuspended in 1ml ace-
tone and incubated at 55◦C for 15 min to extract lycopene.
The supernatant was obtained by filtration through a 0.22
m pore-size nylon membrane for LC–DAD analysis.
Lycopene was detected and measured using an Agilent
LC system with UV/Vis diode array detector. Absorbance
at 450 and 471 nm were monitored and the peak area corre-
sponding to each component integrated to provide a mea-
sure of abundance. The LC column used was an Acquity
UPLC Peptide BEH C18 column (2.1 × 100 mm, 1.7 m,
300 A˚, Waters). LC buffers were 50% of methanol in water
(A) and 25% of ethyl acetate in acetonitrile (B). All the sol-
vents used were HPLC grade. The LC method was 6.5 min-
utes in total with 1.5minutes of post run time (0–1min: 30%
A, 70% B; 1–6 min: 0.1% A, 99.9% B; 6–6.5 min: 30% A,
70% B; at a flow rate of 0.3 ml/min). The injection volume
for the samples was 1 l. Commercially-available lycopene
(Sigma-Aldrich) was dissolved in acetone as a standard and
a standard curve was generated.
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RESULTS
A strategy for functionally-scarless assembly of expression
units
We devised a strategy to mitigate the impact of the scars
normally generated by modular multi-part DNA assembly
methods by exploiting start and stop codons. Start and stop
codons represent natural constraints on DNA sequence de-
sign, as they must occur at the beginning and end of ev-
ery CDS, sites which are particularly sensitive to scars. If
start and stop codons could also be used as fusion sites, then
DNA assembly using these fusion sites would be effectively
scarless at the relevant part junctions, as no additional con-
straints would be introduced by assembly. The type IIS re-
striction endonucleases employed in modular DNA assem-
bly methods are usually (but not always (53)) those which
generate cohesive DNA ends with 4 bp overhangs, such as
BsaI, BbsI or BsmBI (2,54), whereas start and stop codons
are 3 bp long. In order to use start and stop codons as fusion
sites in scarless designs, a type IIS restriction endonuclease
which generates 3 bp overhangs would be required. Several
such endonucleases are known, including the commercially-
available enzyme SapI, which we use here.
Starting with the core concept of start and stop codons
as fusion sites, we designed a generic ‘expression unit’ ar-
chitecture to serve as the first assembly level (Level 1) in
a hierarchical, multi-part, modular DNA assembly frame-
work (Figure 1A) called Start-Stop Assembly, which builds
on the principles of Golden Gate assembly. Each expres-
sion unit for a single protein is divided into four modules;
the promoter, UTR/RBS, CDS and transcriptional termi-
nator; which are key functional modules to allow control
of transcription and translation as independently as possi-
ble. These four modules are delineated from one another
and from a vector by five fusion sites (Figure 1A) which
we named  (alpha),  (beta),  (gamma),  (delta) and
ε (epsilon). To allow multi-part assembly in a single one-
pot restriction-ligation reaction using a single type IIS re-
striction enzyme, the fusion sites must all be of the same
length. First we defined the  fusion site as the sequence
ATG because it is the most common (55,56) and most ef-
ficient (57) start codon, and we defined the  fusion site as
the sequence TAA, which is the most commonly-used stop
codon in synthetic biology, and is efficient in a wide range
of organisms (58). The  fusion site is the junction between
the promoter and the UTR/RBS, where the transcriptional
start site (TSS) is found. In an attempt to minimize any po-
tential impact of the fusion site as a scar in assembled con-
structs, we sought to identify a consensus sequence for the
E. coli TSS which could be used to define the  fusion site.
The sequences of 3746 TSSs previously described in E. coli
MG1655 (59) were aligned (Supplementary Figure S2). A
bias in the frequency of bases was evident at two of the three
positions, but no overall consensus was identified. There-
fore the sequence CCA was assigned to the  fusion site, by
considering both the frequencies of bases at each position in
the TSS alignment and minimizing similarity with the pre-
viously defined  and  fusion sites (Supplementary Figure
S2). There are no natural constraints to guide definition of
the sequences of the  and ε fusion sites, which are the ex-
ternal junctions of each expression unit with the promoter
or terminator, respectively, so we simply designed these to
be as different as possible to the three fusion sites already
defined (,  and ) in order to minimize mis-assemblies.
CAG was assigned to the  fusion site and GGA to the ε
fusion site (Figure 1A).
Requirements for Level 1 assembly of expression units from
Level 0 parts
To assemble expression units using the Level 1 architecture
described above, and to ensure compatibility with efficient
one-pot restriction-ligation assembly reactions, it is neces-
sary for DNA parts (of each type) and vectors to meet cer-
tain specifications. EachDNApartmust begin and endwith
the corresponding fusion sites for the type of part, and in
the case of the ,  and  sites these should be positioned at
the TSS (if known), start codon or stop codon, respectively.
Each part must also be flanked by an inward-facing SapI
recognition site (directionality exists because the recogni-
tion site GCTCTTC is asymmetrical) separated from the
fusion site by a 1 bp spacer (Figure 1A, Supplementary
Figures S7–S10). This arrangement ensures that excision of
each part by SapI will result in cohesive DNA ends with
3 bp 5’ overhangs corresponding to the 3 bp fusion sites.
Appropriately-formatted DNA parts could be generated by
any applicable method such as PCR or DNA synthesis, and
could be used for assembly as either linear DNA or circu-
lar plasmid DNAmolecules. If a part is cloned into a DNA
vector, which is typical, the vector should not contain any
other SapI sites in order to maximize the efficiency of one-
pot restriction-ligation assembly reactions and avoid misas-
sembly and bias. DNA parts should not contain any inter-
nal SapI sites, as these are used in Level 1 assembly; nor any
BsaI sites or BbsI sites, as these are used in later assembly
levels. These sites can be removed from parts and vectors by
conventional methods, or during design of sequences before
DNA synthesis. These specifications define Level 0 (zero) of
Start-Stop Assembly, which represents the initial ‘entry’ or
‘storage’ level of the system.
Instead of numerous entry or storage vectors as required
by some systems, we designed and constructed a single Level
0 vector, named pStA0, for storage of parts of all types in E.
coli (Table 1). For convenience, pStA0 includes a lacZα gene
for blue/white screening and outward-facing BsaI restric-
tion sites for efficient cloning of individual parts using spe-
cial storage acceptor fusion sites (F and R; Supplementary
Figure S3, Note S2). To facilitate storage of parts in Level
0 in the required format, we have defined standard prefix
and suffix sequences (Supplementary Table S1) to be added
to parts either as primer ‘tails’ (Supplementary Table S2)
when PCR-amplifying parts for storage, or when design-
ing part sequences for synthesis. These sequences include
inward-facing BsaI recognition sites and storage donor fu-
sion sites for cloning formatted parts into Level 0 storage
vector pStA0, as well as inward-facing SapI recognition
sites with,,  , or ε donor fusion sites (depending on the
type of part) for subsequent multi-part assembly of expres-
sion units in Level 1 (Supplementary Figure S7–S10, Sup-
plementary Table S1). Finally, assembly requires a Level 1
vector including two outward-facing SapI recognition sites
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A
B
Figure 1. Schematic overview of Start-Stop Assembly. (A) Architecture of Level 1 assembly of expression units from genetic parts, showing detail for the
CDS part in Level 0. Parts stored in Level 0 are flanked by inward-facing SapI restriction sites. Each type of part (promoter, RBS, CDS, terminator) uses
different and unique fusion sites (-ε sites) that allow the correct assembly of expression units. Coding sequences use the start codon ATG ( site) and stop
codon TAA ( site) as fusion sites allowing functionally scarless assembly of expression units. (B) Schematic illustration showing the overall framework for
Start-Stop Assembly. Up to 15 expression units can be hierarchically assembled from basic parts.
with appropriately-positioned  and ε acceptor fusion sites,
but lacking any other SapI sites, for the reasons described
above. These details are made clear by Supplementary Fig-
ure S11.
Validation ofmulti-part DNAassembly using 3 bp fusion sites
The performance of multi-part DNA assembly frameworks
using IIS restriction endonucleases and typical 4 bp fusion
sites is well validated in published studies (3,4), whereas 3
bp fusion sites are rarely used. Our proposed Level 1 archi-
tecture for Start-Stop Assembly using five 3 bp fusion sites
(Figure 1A) might cause performance differences to exist-
ing methods in terms of fidelity or bias of assembly. There-
fore we set out to evaluate and validate assembly using this
Level 1 design alone, independently of a multi-level hier-
archical assembly. For this purpose, it was first necessary
to obtain suitable genetic parts in the Level 0 format de-
scribed above, and a Level 1 vector. A set of six promoters
(Supplementary Table S3) was chosen from a widely-used
(60) library of constitutive E. coli promoters (61). These six
promoters were chosen on the basis of previously-reported
characterization data (61) to span a wide range of expres-
sion strengths, and to be evenly spaced within that range
(Supplementary Figure S5a). Next, we constructed an RBS
library by PCR using degenerate primers and character-
ized 96 individual RBSs (Supplementary Figure S4). Six of
these RBSs (Supplementary Table S3) were chosen to give a
wide and evenly-spaced distribution of expression strengths
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(Supplementary Figure S4 and S5b). Four strong termina-
tors (Supplementary Table S3) with dissimilar sequences
(to minimize the chance of undesirable homologous recom-
bination) were chosen from a previously-characterized li-
brary of terminators (62). To facilitate simple visualization
and measurement of expression, a reporter gene encoding
enhanced yellow fluorescent protein (EYFP) was chosen
as a CDS. The chosen promoters, RBSs, terminators and
EYFP-encoding CDS eyfp were cloned into pStA0 (as de-
scribed in Supplementary Materials and Methods) ready
for use in assembly. We designed and constructed several
Level 1 vectors (Table 1) which are described in more detail
later in this paper. For the purposes of these initial experi-
ments to validate Level 1 assembly, the key features of Level
1 vectors are the two outward-facing SapI recognition sites
with appropriately-positioned  and ε fusion sites (Supple-
mentary Figure S11) and a lacZα gene between the SapI
sites to allow blue/white screening. Two types of assembly
experiments were designed to validate Level 1 assembly, the
first using replicates of assembly of an individual expression
construct to assess fidelity (Figure 2A), and the second us-
ing a combinatorial assembly to assess bias (Figure 2B and
Supplementary Figure S24).
For the experiment to assess fidelity, promoter P3, RBS
R3, terminator T1 (Supplementary Table S3) and the eyfp
CDS were assembled into the Level 1 vector pStA1AZ (Ta-
ble 1) using a one-pot assembly reaction including both
SapI and ligase, as described in the Materials and Meth-
ods section.After incubation, the reaction product was used
to transform E. coliDH10B. Five independent replicates of
this experiment were performed. Blue/white screening us-
ing the lacZα gene of pStA1AZ showed approximately one
blue colony (containing the unmodified pStA1AZ vector)
per 1000 white colonies. The fluorescence of colonies on
agar plates was visualized by illuminating the plates with
blue light, which showed a uniform level of fluorescence
among colonies (Figure 2A). Two colonies from each of the
five replicate experiments were selected at random for anal-
ysis. Sequencing of plasmids purified from these ten clones
showed assembly of the expected parts and correct assembly
of all five fusion sites in all ten constructs (Figure 2A). The
fluorescence of cells of all ten clones, and a pool of several
hundred transformant clones from one transformation, was
determined by flow cytometry analysis of mid-exponential
growth phase cultures. The fluorescence of cells in the pool
was very similar to the fluorescence of cells in the ten veri-
fied, isolated clones (the histogram in Figure 2A shows one
clone, the other clones are shown in Supplementary Figure
S21). These results indicate high fidelity of assembly of the
Level 1 architecture using five 3 bp fusion sites in a one-pot
reaction containing SapI and ligase.
For the experiment to assess bias, an equimolar mixture
of all six promoters, an equimolar mixture of all six RBSs,
CDS eyfp and terminator T1 were combinatorially assem-
bled into the Level 1 vector pStA1AZ using the same pro-
cedures for assembly, transformation and analysis as de-
scribed above for the fidelity experiment, except that the ten
colonies selected at random for analysis were from a sin-
gle assembly and transformation. Colonies on agar plates
illuminated by blue light visibly showed diverse fluores-
cence (Figure 2B). Sequencing of plasmids purified from
the ten clones showed assembly of expected parts and cor-
rect assembly of all five fusion sites in nine of the ten con-
structs. Construct c6 represents a misassembly, as the se-
quence indicates a spurious ligation of a fragment of E. coli
genomic DNA and a fragment of vector DNA in place of
the UTR/RBS part between the  and  fusion sites (Fig-
ure 2B). The sequences of the nine correctly-assembled con-
structs show a variety of combinations of the possible pro-
moters and RBSs. The fluorescence of cells in a pool of sev-
eral hundred transformant clones, determined by flow cy-
tometry as before, spanned a broad range of values from the
negative control (pStA1AZ) to the positive control (which
was the most fluorescent of the ten isolated clones in this ex-
periment). These results are consistent with unbiased com-
binatorial assembly using the Level 1 architecture in a one-
pot reaction. Two further replicates of this assembly experi-
ment were performed, and plasmids from ten clones of each
were sequenced (Supplementary Figure S24) showing simi-
lar diversity and correct assembly in 19 of 20 clones.
A streamlined assembly hierarchy to minimize the number of
destination vectors required for new contexts and organisms
We set out to develop a multi-level hierarchical assembly
framework incorporating the validated Level 1 architecture
to allow assembly of constructs containing multiple expres-
sion units. The structure of the hierarchy is determined by
the identity and arrangement of fusion sites within and be-
tween levels. In a Golden Gate-type multi-level assembly,
vectors at each intermediate level (each level except the first
or last) have both acceptor fusion sites for incorporation of
parts from the preceding level, and donor fusion sites for
subsequent excision of the assembled construct to be used
as a part in the next assembly level. Most multi-level DNA
assembly frameworks do not require a specific pair of fu-
sion sites to be used as the first and last fusion sites in all
assemblies at each level, but instead accommodate differ-
ent combinations of first and last fusion sites, as a way of
flexibly allowing different numbers of parts to be assembled
together. This is achieved by providing sets of multiple al-
ternative vectors at later levels, each with a different pair of
acceptor fusion sites (for example, see Figure 3B). This ap-
proach is effective, but has a major drawback, as it means
that these sets of multiple alternative vectors must be con-
structed for each different destination context, such as plas-
mids with different copy numbers, or shuttle vectors for dif-
ferent organisms, or different integration sites in an organ-
ism. This issue is significant for the use of multi-part DNA
assembly in metabolic engineering, because there are many
different organisms and contexts in which it would be useful
to deploy assembled constructs encoding metabolic path-
ways. This issue does not appear to have been addressed in
the design of previous modular multi-part assembly meth-
ods. We designed a different hierarchy to overcome this is-
sue at the second multi-part assembly level, Level 2, where
it would be most significant.
Level 2 is the destination (final) level for many assemblies.
A typical Golden Gate hierarchy (Figure 3B) allowing as-
sembly of up to five expression units at Level 2 would re-
quire five alternative combinations of acceptor fusion sites,
and therefore five alternative destination vectors, per desti-
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Figure 2. Assessment of fidelity and bias of multi-part Level 1 assembly. Constructs were assembled from Level 0 parts (in storage plasmids) into Level 1
vector pStA1AZ. Promoters, in descending order of strength: P1 = J23100, P2 = J23102, P3 = J23118, P4 = J23107, P5 = J23116, P6 = J23113. RBSs,
in descending order of strength: R1 = RBSc44, R2 = RBSc33, R3 = RBSc13, R4 = RBSc58, R5 = RBSc42, R6 = RBSc36. CDS: e = eyfp. Terminator:
T1 = L3S2P55. Representative images of E. coli DH10B colonies transformed with assembly reactions are shown illuminated by blue light to visualize
fluorescence. In each experiment ten randomly-selected colonies (c1-c10) were analysed by sequencing (with primers oligoGT234 and oligoGT235) and
flow cytometry. Sequencing results show expected intact parts and fusion sites. Flow cytometry histograms show fluorescence intensity of 10,000 events
(cells) normalised to the maximum (in order to visualize distribution rather than absolute values) for wild-type E. coliDH10B as a negative reference (−),
the most fluorescent of the ten clones as a positive reference (+) and a pool of several hundred transformants (P). (A) Assessment of assembly fidelity using
assembly of an individual P3-R3-e-T1 expression unit. Two colonies were randomly selected for analysis from each of five replicate assemblies. The flow
cytometry positive reference (+) strain is c3. (B) Assessment of assembly bias by combinatorial assembly of EYFP expression units using six promoters
P1-P6, six RBSs R1-R6, eyfp and terminator T1. Ten colonies from one assembly were randomly selected for analysis. The flow cytometry positive reference
(+) strain is c1. In the sequencing results the red cross indicates a misassembly between  and  in place of the UTR/RBS. Two further replicates of this
experiment are shown in Supplementary Figure S24.
nation context. Instead, in Start-Stop Assembly we speci-
fied a hierarchy in which one particular pair of fusion sites,
named A and Z, will always be the acceptor sites for Level 2
assembly of Level 1 parts into a Level 2 vector (Figure 3A).
These are a subset of the donor fusion sites of Level 1 vec-
tors (A, B, C, D, E and Z) the rest of which (B, C, D and
E) are used for part-part junctions, but not for part-vector
junctions. The purpose and advantage of this design choice
is that only one vector (with A and Z acceptor fusion sites)
is required at Level 2 regardless of the number of units be-
ing assembled (up to the five-unit maximum limit of Level
2, discussed later). Therefore, any new destination context
(such as a shuttle vector for a different organism) requires
only one new Level 2 vector to be constructed (Figure 3A),
instead of another set of five alternative Level 2 vectors (Fig-
ure 3B). For assembly into A and Z fusion sites at Level 2,
the first Level 1 part to be assembled must begin with an A
fusion site, and the last Level 1 part to be assembled must
end with a Z fusion site. To achieve this while still allow-
ing different numbers of expression units to be assembled
together, one of the Level 1 vectors used in the assembly
must be varied depending upon the number of units to be
assembled. Specifically, for the last expression unit in a se-
ries of units to be assembled, the standard Level 1 vector
is replaced by a ‘Z vector’, in which the second of the two
fusion sites is replaced by aZ fusion site (Figure 3A). For ex-
ample, for the third (and last) unit in a series of three units,
the standard Level 1 vector, with C and D acceptor fusion
sites, is replaced by an alternative Z vector, with C and Z
acceptor fusion sites (Figures 3A, 4, Supplementary Figure
S13).
Effectively, the streamlined hierarchy moves the require-
ment for additional alternative vectors from a destination
level (Level 2) where it is problematic as described above, to
an intermediate, non-destination level (Level 1) where it is
not problematic because the core set of vectors (including
alternative Z vectors) we provide here (Table 1) can be used
for assembly of various numbers of units regardless of any
changes to the final assembly destination vector. The user
need only construct a single new (Level 2) destination vec-
tor per new context or organism.
Assembly efficiency decreases with increasing numbers of
parts (4). Level 2was therefore limited to assembly of amax-
imum of five Level 1 parts (expression units) in order to
maintain a high assembly efficiency, which is important to
ensure that libraries containing large numbers of clones are
readily obtained by combinatorial assembly. To accommo-
date cases which require assembly of greater numbers of ex-
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Figure 3. Alternative hierarchies achieved by alternative organization of Level 1 donor and Level 2 acceptor fusion sites. Rounded rectangles represent
vectors. Letters represent Level 1 donor fusion sites and Level 2 acceptor fusion sites. (A) Start-Stop Assembly uses alternative ‘Z vectors’ at Level 1 to
minimize the number of destination vectors at Level 2. By assembling the last expression unit (of those being assembled at Level 1) in a Z vector at Level
1, in which the last donor fusion site is Z, then the recipient Level 2 vector can always use the same acceptor fusion sites, A and Z. While this requires more
Level 1 vectors, it requires only one Level 2 vector. If alternative destination vectors are required for different organisms or contexts, only one new Level
2 vector needs to be constructed. (B) The typical Golden Gate framework requires multiple Level 2 vectors per context to accommodate all the possible
Level 1 fusion site configurations. Therefore if an alternative destination vector is required several new vectors will need to be constructed per context or
organism.
pression units, we extended the hierarchy to Level 3, which
supports the assembly of up to 15 expression units (Figure
4). Level 2 vectors therefore contain donor fusion sites (re-
ferred to by numbers 1, 2, 3 or 4) to allow excision of Level
2 assembled constructs for use as parts in Level 3 assembly,
and Level 3 vectors contain different combinations of the
corresponding acceptor fusion sites. Extending the hierar-
chy to Level 3 requires additional Level 2 vectors (Figure 4,
Table 1). However, the advantage of the streamlined hier-
archy described above (and emphasized in Figure 3) is not
lost, because when Level 3 assembly is used, the destination
vector will be at Level 3, and Level 2 will serve as an inter-
mediate level, not a destination level, so the Level 2 vectors
already provided here can be used. Therefore it is still only
necessary for the user to construct one or possibly two new
(Level 3) destination vector(s) per new context or organism.
Implementation of the complete multi-level Start-Stop As-
sembly system
Having established the details of the architecture of Level
0 and Level 1 (Figure 1A), and the overall assembly hier-
archy for all levels (Figures 1B, 4), we proceeded to resolve
all remaining design details and implement Start-Stop As-
sembly as a complete modular DNA assembly system with
a widely-applicable set of 15 core vectors (Figures 1B, 4).
First, we defined the details of Level 2 assembly and Level
3 assembly. Unlike Level 1 assembly of expression units
from Level 0 parts, fusion sites for Level 2 assembly and
Level 3 assembly can be located outside regions that are
acutely sensitive to scar sequences. Therefore for Level 2
and Level 3 assembly we simply chose type IIS restriction
endonucleases and fusion site sequences from among those
reported and validated previously.We chose the type IIS en-
zyme BsaI for Level 2 assembly and BbsI for Level 3 as-
sembly, both of which are commonly used in Golden Gate-
based methods (4,63). Restriction of DNA by BsaI or BbsI
yields cohesive DNA ends with 4 bp overhangs, which cor-
respond to 4 bp fusion sites. We assigned 4 bp sequences
to the fusion sites A (GGAG), B (AATG), C (AGGT), D
(GCTT), E (CGCT) and Z (TACT) for Level 2 assembly
of Level 1 parts into a Level 2 vector. We assigned 4 bp se-
quences to the fusion sites 1 (TGCC), 2 (ACTA), 3 (TTAC)
and 4 (CGAG) for Level 3 assembly of Level 2 parts into
a Level 3 vector. All these sequences have previously been
shown to provide high-fidelity assembly (4).
Each of the 15 core Start-Stop Assembly vectors contain
a similar assembly cassette to facilitate the initial cloning of
parts at Level 0 and their subsequent hierarchical assem-
bly through one or more further Levels (Table 1, Figure
4). In the centre of each cassette is a lacZα gene flanked
by the relevant acceptor fusion sites, with outward-facing
recognition sites for the corresponding type IIS restriction
endonuclease, positioned appropriately to ensure cohesive
DNA ends correspond to the fusion sites. This arrange-
ment allows blue/white screening (in suitableE. coli strains)
for replacement of the lacZα gene upon successful assem-
bly using the acceptor fusion sites. Outside the acceptor fu-
sion sites are the relevant donor fusion sites, with inward-
facing recognition sites for the corresponding type IIS re-
striction endonuclease (except in Level 3 vectors, which lack
donor fusion sites) positioned appropriately to ensure cohe-
sive DNA ends correspond to the fusion sites. Finally, the
fusion sites are flanked by the strong, rho-independent tran-
scriptional terminators T0 of phage lambda and T1 of the
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Figure 4. Detail of multi-part hierarchical assembly and fusion sites used in Start-Stop Assembly. Up to 15 expression units can be hierarchically assembled
from basic parts (promoters, RBSs, CDSs and terminators) stored at Level 0. Level 1 expression units are assembled from four Level 0 parts, Level 2
constructs are assembled from up to five Level 1 expression units, and Level 3 constructs are assembled from up to three Level 2 constructs. Different type
IIS restriction endonucleases (SapI, BsaI or BbsI) and different antibiotic-resistance markers (AmpR, TetR, KanR or CamR) are used for each assembly
level as shown. Acceptor fusion sites are shown inside donor fusion sites at Level 1 and Level 2. Only donor fusion sites are shown at Level 0, and only
acceptor fusion sites are shown at Level 3. As described in the text, alternative sets of vectors are used at Level 1 depending upon the number of expression
units being assembled, such that the first and last Level 1 donor fusion sites are always A and Z, respectively, which are always the Level 2 acceptor fusion
sites. Multiple Level 2 vectors (pStA212, pStA223, pStA234) with different donor fusion sites are only needed if the assembly will be continued to Level 3,
in order to assemble more than five expression units. Alternative Level 3 vectors (pStA313, pStA314) with different acceptor fusion sites allow for assembly
of two or three Level 2 constructs.
rrnB operon ofE. coli (64). These terminators transcription-
ally insulate cloned parts and assembled constructs from
the rest of the vector, preventing transcriptional ‘read-in’
and/or ‘read-out’ which might interfere with the function
of either assembled sequences or the vector.
We constructed a core set of 15 vectors including assem-
bly cassettes, with fusion sites described above, in combi-
nations shown in Table 1 and Figure 4. To avoid carry-
over of plasmids from one level to the next during assem-
bly, we designed each level to encode a different antibiotic
resistance from the next (Table 1, Figure 4), as in other
multi-level assembly systems (4,5,63). We designed Level 1,
Level 2 and Level 3 vectors to use the low copy-number
replicon p15A (10–12 copies per cell (65)) in order to min-
imize the burden imposed on cells by the complete, func-
tional expression units assembled at these levels. The use
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of low copy-number replicons to reduce deleterious effects
should improve the success of assembly of constructs ex-
pressing metabolic pathways and minimize bias in combi-
natorial assembly. Level 0 (part storage) does not involve
functional expression units, so a low-copy number repli-
con would be less useful at Level 0. Instead, to allow more
convenient preparation and sequence-verification of parts
cloned in the Level 0 vector, a high copy-number replicon
pMB1 (500–700 copies per cell (66)) was used. These combi-
nations of antibiotic resistances and repliconswere achieved
by constructing the 15 core vectors from the classic vectors
pUC19, pACYC177 or pACYC184 (Supplementary Mate-
rials and Methods). SapI, BsaI and BbsI restriction sites
are reserved for assembly, so were removed from all the
vectors by conventional methods (Supplementary Materi-
als and Methods), except for the intended positions in the
assembly cassettes. Validated primers for sequencing parts
or assembled constructs at all levels are listed in Supple-
mentary Table S4. In order to apply Start-Stop Assembly to
new destination contexts (such as organisms or integration
sites), alternative Level 2 or Level 3 destination vectors can
be constructed simply by installing suitable combinations
of restriction sites and fusion sites (typically by transfer-
ring the entire assembly cassette from an existing Level 2 or
Level 3 vector; Supplementary Figure S6) into the alterna-
tive vector backbone, and removing any other BsaI and/or
BbsI sites.
Start-Stop Assembly allows assembly of independent
monocistronic expression units, which have advantages over
operons, particularly as they allow greater independence of
expression units, and more fine-grained control of expres-
sion, as both promoters and RBSs can be varied for each
unit. However, there are scenarios in which operon configu-
rations may be preferred, such as the co-regulation of multi-
ple expression units by a single regulated promoter, as found
in natural operon systems (67,68), or to cause the expression
levels of multiple units to be partially linked in combina-
torial designs (30–32), or to allow a metabolic pathway or
other system to be optimized under the control of one pro-
moter and then subsequently, once optimized, placed under
the control of a different promoter suited to a particular ap-
plication. To allow operon configurations within the same
overall framework, we generated short spacer sequences
which can be used in place of a promoter and/or termina-
tor in Level 1 assembly of an expression unit. This approach
can be used to generate Level 1 units suitable for the start of
an operon (with a spacer in place of a terminator), the end
of an operon (with a spacer in place of a promoter), or the
middle of an operon (with spacers in place of both promoter
and terminator). A set of 16 spacers designed to be orthog-
onal and biologically-neutral, each 12 bp in length, were
generated using the R2oDNA designer software (69) (Sup-
plementary Table S5). As the spacers are short, it is con-
venient to implement these spacer parts as linkers, by an-
nealing partially complementary pairs of oligonucleotides
to obtain double-stranded linkers with cohesive ends corre-
sponding to fusion sites (SupplementaryTable S5). For each
spacer sequence, two such linkers were designed, the first
with  and  cohesive ends, suitable for Level 1 assembly in
place of a promoter; and the second with  and ε cohesive
ends, suitable for Level 1 assembly in place of a termina-
tor. These linkers can be used directly in a Level 1 assembly
reaction (Supplementary Materials and Methods).
Combinatorial Start-Stop Assembly of metabolic pathways
provides exploration of design space, phenotypic diversity and
high-performance pathway configurations
We set out to establish Start-Stop Assembly as an effec-
tive and generally-applicable platform for the implemen-
tation and optimization of metabolic pathways. We aimed
to validate (i) combinatorial assembly of constructs en-
coding (ii) effective metabolic pathways (iii) composed of
numerous enzymes (iv) in monocistronic, operon and hy-
brid configurations and (v) with wide exploration of de-
sign space demonstrated by observable phenotypic proper-
ties.Metabolic pathways for the biosynthesis of carotenoids
are ideal for these purposes, because differently-coloured
compounds are formed at several steps in the pathways, in-
cluding the final products. These red, yellow and orange
colours effectively serve as an indirect, semi-quantitative
readout of the balance between the fluxes in the pathway,
caused by the relative expression levels of the enzymes cat-
alyzing the various steps. Diversity and performance of
carotenoid pathway configurations is therefore readily ob-
served. Carotenoid pathways have been used in this way pre-
viously (32,43,70). Furthermore, carotenoids are valuable
compounds with useful properties used in the pharmaceu-
tical, food and cosmetic industries (71).
We used Start-Stop Assembly to combinatorially as-
semble, in E. coli, five libraries of constructs encod-
ing carotenoid metabolic pathways. Four of these li-
braries (pGT531–534, Supplementary Figure S16–19) en-
code pathways for the product -carotene (Supplementary
Figure S15a) using four heterologous CDSs (crtE, crtB, crtI
and icyB) plus the native E. coli CDS dxs (encoding an en-
zyme in the upstream MEP pathway which is known to
be rate-limiting in E. coli (32,72–74)) making five CDSs in
total. The four -carotene pathway libraries use different
monocistronic, operon or hybrid configurations to confirm
that these configurations perform as expected in Start-Stop
Assembly. The fifth pathway library (pGT535) includes the
same five CDSs as the -carotene pathway libraries plus
three additional CDSs (idi, crtZ and crtW), which extend
the pathway to the product astaxanthin (Figure 5a), mak-
ing eight CDSs in total (Supplementary Figure S20). The
eight CDSs (detailed in the Materials and Methods sec-
tion) were cloned into the Level 0 vector pStA0 (Supple-
mentary Table S3). Pathway libraries were combinatorially
assembled using these CDSs and the sets of six promot-
ers, six RBSs and (individually) four terminators generated
earlier (Supplementary Table S3) in order to vary the ex-
pression of each enzyme widely. Combinatorial variation
was introduced by using equimolar mixtures of the six pro-
moter parts or six RBS parts at each appropriate position
in Level 1 assemblies, then propagated to subsequent assem-
bly levels through hierarchical assembly. In operon designs,
spacers (described earlier, and shown in Supplementary Ta-
ble S5) were used in place of promoters and terminators at
appropriate positions as shown in Figures S17–20, which
also show the vectors used. The first -carotene pathway
library (pGT531) was assembled in a monocistronic con-
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Figure 5. Combinatorial assembly of astaxanthin pathway using Start-Stop Assembly. (A) Astaxanthin pathway showing the endogenous enzymes of the
E. coli MEP pathway and heterologous enzymes. Coloured products are shown in boxes, enzymes included in the combinatorial assembly are shown
above arrows. Abbreviations: G3P (glyceraldehyde 3-phosphate), FPP (Farnesyl pyrophosphate), GGPP (Geranylgeranyl pyrophosphate). (B) Design of
astaxanthin pathway library pGT535, composed of eight expression units combinatorially and hierarchically assembled into Level 3 vector pStA314, as
outlined in the text and shown in detail in Figure S20. Mixtures of six parts of varying strengths were used at each promoter and RBS position shown,
as described in the text. These are shown as n in the figure to reflect the sample of the combinatorial design space present after hierarchical assembly.
Assembled insert size = 9,984 bp. Total size of plasmid including assembled insert = 12,691 bp. (C) Phenotypic variation among E. coli clones of the
astaxanthin pathway library (pGT535) was compared to controls pStA314 (empty vector) and an isolated clone pGT536 from the astaxanthin pathway
library pGT535. Phenotypic variation is shown using representative images of colonies, histograms of colony size (measured as colony area in pixels, x-axis
values represent the upper limit of each histogram bin) and the distributions of colony colours (represented using red, green and blue values extracted from
colony images).
figuration in the destination vector pStA212 (Supplemen-
tary Figure S16). Due to the mixtures of six promoter parts
and mixtures of six RBS parts used, and the ten combi-
natorial positions (Supplementary Figure S16), the maxi-
mum possible library size was 610 (6.05 × 107). In the sec-
ond -carotene pathway library (pGT532) the same five
CDSs were used, but in an operon configuration, assembled
in pStA223, accordingly with a much smaller maximum li-
brary size of 66 (4.67 × 104, Supplementary Figure S17).
The third -carotene pathway library (pGT533) was con-
structed in pStA234 in a hybrid configuration, composed
of a three-unit operon and two monocistronic units, with a
maximum library size of 68 (1.68× 106, Supplementary Fig-
ure S18). The fourth -carotene pathway library (pGT534)
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was also assembled in a hybrid configuration, composed of
a four-unit operon and one monocistronic unit, which was
assembled in pStA313 with a maximum library size of 67
(which equals 2.80 × 105, Supplementary Figure S19). The
astaxanthin pathway library (pGT535) was combinatorially
assembled in pStA314 in a hybrid configuration, composed
of a four-unit operon, amonocistronic unit, and a three-unit
operon. For the astaxanthin pathway library, the maximum
library size was 611 (3.63× 108, Supplementary Figure S20).
In each case, the pathway libraries were generated by
hierarchical assembly using one-pot assembly reactions at
each step, then pooling all white colonies (typically 99% of
colonies were white and 1% were blue) obtained at each in-
termediate step to prepare plasmidDNA for use as the com-
binatorial mixture of parts for the subsequent step. Each
transformation yielded at least thousands of colonies, and
typically tens of thousands of colonies, providingmany-fold
coverage at the Level 1 assembly steps (at which the maxi-
mum library size was 62 = 36) and typically partial coverage
at the Level 2 and Level 3 assembly steps (at which the max-
imum library size was between 66 (4.67 × 104) and 611 (3.63
× 108)), so each library of clones obtained as colonies on
plates at the end of each hierarchical assembly represents a
sample of the possible pathway variants.
As the combinatorial libraries were designed to vary
the expression of each enzyme in the carotenoid pathways
widely, we expected to observe colonies of a range of colours
and intensities of those colours caused by differing amounts
of the various carotenoids. The astaxanthin pathway li-
brary in particular could produce up to five coloured com-
pounds (Figure 5A, B). We also expected colony sizes to
vary widely, reflecting growth impairments caused by pro-
tein over-expression and/or by central metabolites being di-
rected away from native metabolism to carotenoid biosyn-
thesis. Diversity of colony colour and size were both clearly
evident by eye, and we analysed images of plates of colonies
to measure these effects more objectively (Figure 5C, Sup-
plementary Figure S15). In comparison to controls (the
empty vector pStA314 and an isolated clone pGT536 from
the astaxanthin pathway library pGT535) the distribution
of colony sizes in the astaxanthin pathway library pGT535
was shifted towardsmuch smaller colonies, and the colonies
showed a wide distribution of colours not seen in the con-
trols (Figure 5C). Interestingly, colony colours were not as-
sociated with with colony size (linear regression R2 values
<0.2, Supplementary Figure S22), and colonies of similar
colours but very different sizes were observed. Similar re-
sults were obtained with the four different -carotene path-
way libraries, among which some differences were observed
in both colony size distributions and colony colour distri-
butions (Supplementary Figure S15 and S23), presumably
caused by the different designs of the pathway libraries. Fi-
nally, as a simple measure of the effectiveness of the path-
way variants obtained, and to place the observed concen-
trations and variation in the context of previously-reported
carotenoid biosynthesis, ten clones were picked at random
from the astaxanthin pathway library and analysed for their
production of lycopene (Figure 6). Lycopene is the first
coloured carotenoid in the pathway, and several literature
reports quantify lycopene production by engineered E. coli,
allowing comparison. In simple, small-scale batch cultures
Figure 6. Lycopene content of E. coli clones from the astaxanthin library.
Ten E. coli colonies were randomly selected from the combinatorially-
assembled astaxanthin pathway library pGT535 (Figure 5, Figure S20).
Each clone was grown for 24 h in LB broth before lycopene content was
determined as mg lycopene per dry cell weight (DCW). Error bars repre-
sent the standard deviation of three independent biological replicates. A
photograph of a sample of the culture of each clone was taken (shown to
left of graph), which shows the visible variation of colour in the ten cul-
tures, attributed to their different profiles of the carotenoids produced in
the astaxanthin pathway.
over 24 h we observed different lycopene concentrations
from 0 mg/g DCW to 108 mg/g DCW, a similar range to
previous comparable studies (43,75,76), indicating that the
variants obtained here represent diverse and effective path-
way implementations.
DISCUSSION
AllDNAassemblymethods impose constraints of one form
or another on the design and assembly of sequences and li-
braries. Operating within the relevant constraints is a nec-
essary compromise to use an assembly method and benefit
from its advantages. However, is it generally preferable to
avoid unnecessary design constraints where possible. Here,
we develop and validate Start-Stop Assembly, which pro-
vides the same key advantages as other Golden Gate-type
modular assembly frameworks; particularly efficient, un-
biased, multi-part, hierarchical assembly; but also allows
designs to be scarless at CDS boundaries, which are cru-
cial, highly-sensitive sites where scars affect mRNA struc-
ture and the activity of the RBS (as demonstrated by our
direct comparison of the impact of scars in Supplementary
Figure S1) and potentially other functional RNA features.
By comparison to Start-Stop Assembly, the scars at CDS
boundaries in other modular DNA assembly methods rep-
resent avoidable design constraints. The second key distinc-
tive advantage of Start-StopAssembly is the streamlined hi-
erarchy, which means that typically only one new vector is
required in order to assemble constructs for any new desti-
nation context (Figure 3). This should facilitate more rapid
and convenient development of engineered metabolic path-
ways for diverse non-model organisms in order to exploit
their industrial potential.
The main disadvantage of using start and stop codons
for assembly is the incompatibility of this approach with
the construction of fusion proteins from domains and/or
tags, as this requires fusion sites which do not start or stop
translation. Fortunately, combinatorial construction of fu-
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sion proteins is infrequently used in most metabolic engi-
neering. If required, individual fusion proteins could be in-
cluded in Start-Stop Assembly simply by generating Level 0
CDS parts encoding complete fusion proteins in advance of
assembly. Similarly, the Level 1 architecture does not sub-
divide the four functional modules (promoter, UTR/RBS,
CDS and terminator), which might be useful for example
to generate promoters composed of multiple regulatory el-
ements, but these could simply be constructed as individ-
ual promoter parts, particularly given the modest number
of combinations that are likely to be required.
To the best of our knowledge, there is only one previ-
ous description of a DNA assembly method which is both
modular and scarless, called ‘scarless stitching’ (31). This
method uses Golden Gate-like restriction-ligation and fu-
sion sites, but is necessarily limited to assembly of only two
parts in each step due to an additional blunt restriction-
ligation reaction used to delete ‘bridging’ (scar) sequences.
Hierarchical assembly of metabolic pathways using scar-
less stitching would require many more steps in series and
in parallel than multi-part methods like Start-Stop Assem-
bly. Another previous study constructed single-gene expres-
sion plasmids for Agrobacterium transformation of plants
by fusing a promoter to a reporter gene, in some cases via
the start codon using SapI, although this approach was not
broadly-applicable and supported only up to two parts (53).
This work has focused on construction of prokaryotic ex-
pression constructs, but the system can readily be applied
to construction of eukaryotic expression constructs using
the same framework of fusion sites, hierarchy, storage vec-
tor and assembly vectors, simply by cloning suitable parts in
the Start-Stop Assembly format and constructing a suitable
destination vector.
The assembly and analysis of the carotenoid pathway li-
braries validates Start-Stop Assembly as a platform for the
implementation and optimization of metabolic pathways,
as (i) the diversity of colony colour and colony size phe-
notypes reflects the intended wide exploration of design
space, (ii) the effectiveness of pathway variants, reflected by
carotenoid colours and lycopene concentrations, indicates
the absence of emergent issues caused by novel combina-
tions and arrangements of fusion site sequences, and (iii)
all 15 core assembly vectors (Table 1) were successfully used
during the construction of these five pathway libraries. The
aim of these single-round experiments was to validate the
approach, not to maximize production, although the re-
sults compare well to other reports (43,75,76). The observed
lack of association between colony colour and colony size
(Supplementary Figures S22 and S23) suggests that differ-
ent variants encode similarly productive pathways while im-
posing very different growth impairments on the host cell,
and may reflect trade-offs between transcription and trans-
lation (37,77). This indicates that optimization of metabolic
pathways through their enzyme expression profile is impor-
tant to obtain high-performing, low-burden pathway imple-
mentations, and is readily achieved by combinatorial assem-
bly of suitable parts.
Multi-part DNA assembly methods are relatively com-
plex by comparison to conventional restriction cloning,
which poses a barrier to their widespread adoption, partic-
ularly if the advantages are not clear and the constraints are
onerous, or appear so. Thus in this report we have aimed to
provide sufficient detail to make Start-Stop Assembly very
accessible, including to those who are unfamiliar with other
multi-part DNA assembly methods. Much of this detail is
found in the Supplementary Materials which include nu-
merous figures and tables, a quick-start guide, and a lab-
oratory protocol. The assembly of carotenoid pathway li-
braries in this study provides an exemplar and template for
those seeking to use combinatorial assembly to construct
and optimize metabolic pathways. We make available to the
community (through Addgene) a kit of the 15 core stor-
age and assembly vectors (Table 1) as well as all the pro-
moters, RBSs, CDSs and terminators (in storage plasmids,
Supplementary Table S3) used successfully in the examples
shown here. We suggest that a straightforward way for a re-
search group to establish combinatorial multi-part assem-
bly of metabolic pathways is to first directly reproduce one
of the carotenoid libraries described here as a positive con-
trol, which provides immediate visual feedback of success in
the form of colony colours and sizes, and then to simply re-
peat the assembly replacing carotenoid pathway CDS parts
with CDS parts for the pathway of interest.
As combinatorial multi-part assembly becomes more
routine and widespread, supporting the construction of
large libraries, the challenge and focus of effort in the devel-
opment of metabolic pathways is changing. Assembly itself
is straightforward, but even the largest libraries inevitably
represent only small samples of the very large possible de-
sign spaces, so it is not feasible to exhaustively screen all
possible variants for the best-performing and least burden-
some pathway variants. Effective strategies are needed first
to design the granularity and distribution of fractional sam-
pling of large pathway design spaces given a priori infor-
mation, and then to iteratively optimize designs by mov-
ing through design space towards progressively better path-
way variants. Such strategies have become the main subject
of various recent studies (31,41,78,79). This is a significant
development reflecting the evolving role of systematic syn-
thetic biology approaches in underpinning increasingly ef-
fective metabolic engineering and industrial biotechnology.
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Supplementary Data are available at NAR Online.
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